A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.  Exact Sciences, which is headquartered in the UW Research Park and has labs along ...

My two sons carry a family medical history that makes prostate cancer a very real concern. Their biological father was ...

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

A recent study shows that cancer survivors’ out-of-pocket costs for necessary medical equipment are sometimes so high that ...

Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect™ molecular residual disease (MRD) test has received Medicare ...

Overall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This ...